Clincosm LogoSign in Get a demo

borderline resectable pancreatic cancer

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Borderline Resectable Pancreatic Cancer Trial in Verona (Intraoperative radiotherapy)

Suspended
  • Borderline Resectable Pancreatic Cancer
  • Intraoperative radiotherapy
  • Verona, Italy
    General and Pancreatic Surgery Unit, Pancreas Institute, Univers
Nov 1, 2022

SBRT, Borderline Resectable Pancreatic Cancer, Unresectable Pancreatic Cancer Trial in Worldwide (Drug GC4711, Placebo)

Recruiting
  • SBRT
  • +2 more
  • Drug GC4711
  • Placebo
  • Gilbert, Arizona
  • +23 more
Aug 12, 2022

Borderline Resectable Pancreatic Cancer, Locally Advanced Pancreatic Adenocarcinoma Trial in Shanghai (Nab paclitaxel plus

Recruiting
  • Borderline Resectable Pancreatic Cancer
  • Locally Advanced Pancreatic Adenocarcinoma
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Jan 27, 2022

Borderline Resectable Pancreatic Cancer Trial (FOLFIRINOX, gemcitabine + nab-paclitaxel)

Active, not recruiting
  • Borderline Resectable Pancreatic Cancer
  • (no location specified)
Sep 8, 2020

Borderline Resectable Pancreatic Cancer Trial in Beijing (nab-paclitaxel and S-1)

Unknown status
  • Borderline Resectable Pancreatic Cancer
  • nab-paclitaxel and S-1
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Mar 8, 2020

Borderline Resectable Pancreatic Cancer Trial in Pittsburgh (gemcitabine/nab-paclitaxel, mFOLFIRINOX)

Terminated
Has Results
  • Borderline Resectable Pancreatic Cancer
  • Pittsburgh, Pennsylvania
    Hillman Cancer Center
Jun 30, 2018

Pancreatic Cancer, Locally Advanced Pancreatic Cancer, Neoadjuvant Therapy Trial in Nanjing (Artery Divestment Technique,

Unknown status
  • Pancreatic Cancer
  • +3 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Feb 18, 2018